Chronis Aris, Thomopoulos Konstantinos, Sapountzis Apostolos, Triantos Christos, Kalafateli Maria, Kalofonos Charalampos, Nikolopoulou Vassiliki
Department of Internal Medicine, Division of Gastroenterology, University Hospital, Patras, Greece.
Clin Exp Gastroenterol. 2011;4:257-61. doi: 10.2147/CEG.S25594. Epub 2011 Nov 15.
Adiposity has been thought to be related to colorectal carcinogenesis. The aim of this study was to explore any association between obesity factors and the presence of colorectal adenoma, a potential precancerous lesion.
Two hundred and six consecutive patients undergoing colonoscopy without colorectal cancer were enrolled in the study. Anthropometric measures and other adiposity-related laboratory variables including insulin resistance and serum adiponectin levels were recorded and correlated with the presence of adenoma.
Colorectal adenoma was detected in 68/206 patients (33%), tubular adenoma(s) in 38 patients, and tubulovillous or villous in 30 patients. Twenty-one patients (10.2%) had at least one proximal polyp. The size of the largest adenoma was ≤10 mm in 40 patients and >10 mm in 28 patients. No statistically significant difference was observed in body mass index, waist circumference, fasting plasma glucose concentration, insulin, homeostatic metabolic assessment, cholesterol, low-density lipoproteins, high-density lipoprotein, or triglycerides between patients with and without adenoma. In addition, there was no difference in plasma adiponectin between patients with adenoma (11.1 ± 6 μg/mL) and controls (10.2 ± 7.8 μg/mL). Furthermore, no significant difference in any parameter was found between patients with advanced adenoma and no advanced adenoma, nor between patients with proximal or distal tumors.
This study found that the presence of colorectal adenoma is not correlated with any adiposity factor. Moreover, obesity does not appear to be associated with the site or the presence of more advanced lesions.
肥胖一直被认为与结直肠癌的发生有关。本研究旨在探讨肥胖因素与结直肠腺瘤(一种潜在的癌前病变)的存在之间的任何关联。
连续纳入206例接受结肠镜检查且无结直肠癌的患者。记录人体测量指标和其他与肥胖相关的实验室变量,包括胰岛素抵抗和血清脂联素水平,并将其与腺瘤的存在情况进行关联分析。
206例患者中有68例(33%)检测到结直肠腺瘤,38例为管状腺瘤,30例为管状绒毛状或绒毛状腺瘤。21例患者(10.2%)至少有一个近端息肉。最大腺瘤的大小≤10 mm的有40例,>10 mm的有28例。腺瘤患者与无腺瘤患者在体重指数、腰围、空腹血糖浓度、胰岛素、稳态代谢评估、胆固醇、低密度脂蛋白、高密度脂蛋白或甘油三酯方面未观察到统计学上的显著差异。此外,腺瘤患者(11.1±6 μg/mL)与对照组(10.2±7.8 μg/mL)的血浆脂联素水平也无差异。此外,进展期腺瘤患者与非进展期腺瘤患者之间,以及近端或远端肿瘤患者之间,在任何参数上均未发现显著差异。
本研究发现结直肠腺瘤的存在与任何肥胖因素均无相关性。此外,肥胖似乎与病变部位或更晚期病变的存在无关。